Market By Technology, Application, Product, And Region | Forecast 2019-2027
Research by Triton suggests the Asia-Pacific metagenomics market to progress at a CAGR of 16.32% in the upcoming years from 2019 to 2027.
The countries studied in the metagenomics market in the Asia-Pacific include:
• India
• China
• Japan
• South Korea
• Australia & New Zealand
• ASEAN countries
• Rest of APAC
The increase in the middle-class population, the improvement in medical infrastructure, and the increasing prevalence of chronic & non-chronic diseases, along with the rising penetration of health insurance, are driving the growth of India’s pharma sector, as well as that of the metagenomics sector. According to India Brand Equity Foundation, the Indian biotechnology industry (which is comprised of bio-pharmaceuticals, bio-agriculture, bioinformatics, bio-services, and bio-industry), is expected to grow significantly in the coming years. The biopharma sector (consisting of vaccines, therapeutics and diagnostics), will be the largest contributor to this growth. This will provide a push to the metagenomics market in India over the forecast period.
It is mandatory for The Korean Ministry of Health and Welfare to provide universal healthcare insurance to its residents. South Korea has a robust healthcare infrastructure and offers top-notch and affordable treatment to its population. As stated by the WHO in 2017, the country ranks eleventh in the world in terms of highest life expectancy, with an average life expectancy of 82. However, sedentary and unhealthy lifestyles, have led to an increase in the incidence of non-communicable diseases (NCDs). Besides, a significant percentage of the population in the country is reported to have diabetes. One-seventh of those aged over 30, and one-third of those above 65 years of age in South Korea suffer from the disease. The above-mentioned statistics indicate a potential for positive growth for the metagenomics market in the country.
Takara Holdings Inc. operates its business through the Takara Bio Group, Takara Healthcare, and Takara Shuzo Group. Out of these, The Takara Bio Group is invested in the biomedical business. The company is known for its ThruPLEX DNA-seq kit. The Japan-based company is headquartered in Kusatsu, Shiga. In April 2019, Takara Bio announced it would be acquiring an exclusive license to use the patented technology relating to new-generation car gene therapy.
Some of the companies present in the metagenomics market are Bio-Rad Laboratories Inc., Qiagen N.V., Enterome SA, Swift Biosciences Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Thermo Fisher Scientific Inc., Illumina Inc., PerkinElmer Inc., Integragen SA, Oxford Nanopore Technologies Ltd., Pacific Biosciences Of California Inc., Takara Bio Inc., GenoScreen, and Novogene Co. Ltd.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
METAGENOMICS MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE
2.2.3. BARGAINING
POWER OF SUPPLIERS
2.2.4. BARGAINING
POWER OF BUYERS
2.2.5. THREAT
OF COMPETITIVE RIVALRY
2.3. MARKET
ATTRACTIVENESS INDEX
2.4. MARKET
PLAYER POSITIONING
2.5. KEY
INSIGHT
2.6. MARKET
DRIVERS
2.6.1. GROWING
AWARENESS AND DEVELOPMENT IN PLATFORMS AND SEQUENCING DEVICES
2.6.2. INCREASE
IN COLLABORATION BETWEEN METAGENOMIC EXPERIMENTS AND COMPUTING TECHNOLOGIES
2.6.3. EXPANSION
OF METAGENOMICS APPLICATIONS
2.7. MARKET
RESTRAINTS
2.7.1. STRINGENT
REGULATORY FRAMEWORK
2.7.2. UNAVAILABILITY
OF SKILLED PROFESSIONALS
2.8. MARKET
OPPORTUNITIES
2.8.1. INCREASING
GOVERNMENT INITIATIVES IN THE DEVELOPING ECONOMIES
2.8.2. DEVELOPMENTS
IN NEXT-GENERATION SEQUENCING (NGS) PROCESS
2.9. MARKET
CHALLENGES
2.9.1. CHALLENGES
ASSOCIATED WITH DNA SEQUENCING PROCESS OR TECHNIQUES
2.9.2. BIOINFORMATICS
LIMITATION IN DNA SEQUENCING
3. METAGENOMICS
MARKET OUTLOOK – BY TECHNOLOGY
3.1. SEQUENCING
3.2. BIOINFORMATICS
4. METAGENOMICS
MARKET OUTLOOK – BY APPLICATION
4.1. GUT
MICROBE CHARACTERIZATION
4.2. INFECTIOUS
DISEASE DIAGNOSIS
4.3. BIOTECHNOLOGY
4.4. ENVIRONMENTAL
REMEDIATION
4.5. BIOFUEL
4.6. AGRICULTURE
5. METAGENOMICS
MARKET OUTLOOK – BY PRODUCT
5.1. CONSUMABLES
5.2. INSTRUMENTS
5.3. SOFTWARE
6. METAGENOMICS
MARKET – REGIONAL OUTLOOK
6.1. ASIA-PACIFIC
6.1.1. COUNTRY
ANALYSIS
6.1.1.1. JAPAN
6.1.1.2. CHINA
6.1.1.3. AUSTRALIA
& NEW ZEALAND
6.1.1.4. INDIA
6.1.1.5. SOUTH
KOREA
6.1.1.6. ASEAN
COUNTRIES
6.1.1.7. REST
OF ASIA-PACIFIC
7. COMPANY
PROFILES
7.1. BIO-RAD
LABORATORIES, INC.
7.2. QIAGEN
N.V.
7.3. ENTEROME
SA
7.4. SWIFT
BIOSCIENCES, INC.
7.5. F.
HOFFMANN-LA ROCHE LTD.
7.6. AGILENT
TECHNOLOGIES, INC.
7.7. THERMO
FISHER SCIENTIFIC, INC.
7.8. ILLUMINA,
INC.
7.9. PERKINELMER,
INC.
7.10. INTEGRAGEN
SA
7.11. OXFORD
NANOPORE TECHNOLOGIES LTD.
7.12. PACIFIC
BIOSCIENCES OF CALIFORNIA, INC.
7.13. TAKARA
BIO, INC.
7.14. GENOSCREEN
7.15. NOVOGENE
CO., LTD.
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1 ASIA-PACIFIC METAGENOMICS MARKET
2019-2027 ($ MILLION)
TABLE 2 COMPANY’S MARKET POSITION OUTLOOK IN
2017 (%)
TABLE 3 ASIA-PACIFIC METAGENOMICS MARKET BY
TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 4 ASIA-PACIFIC METAGENOMICS MARKET BY
APPLICATION 2019-2027 ($ MILLION)
TABLE 5 ASIA-PACIFIC METAGENOMICS MARKET BY
PRODUCTS 2019-2027 ($ MILLION)
TABLE 6 ASIA-PACIFIC METAGENOMICS MARKET BY
COUNTRY 2019-2027 ($ MILLION)
FIGURE 1 ASIA-PACIFIC METAGENOMICS MARKET 2019-2027
($ MILLION)
FIGURE 2 ASIA-PACIFIC METAGENOMICS MARKET BY
SEQUENCING 2019-2027 ($ MILLION)
FIGURE 3 ASIA-PACIFIC METAGENOMICS MARKET BY
BIOINFORMATICS 2019-2027 ($ MILLION)
FIGURE 4 ASIA-PACIFIC METAGENOMICS MARKET BY GUT
MICROBE CHARACTERIZATION 2019-2027 ($ MILLION)
FIGURE 5 ASIA-PACIFIC METAGENOMICS MARKET BY
INFECTIOUS DISEASE DIAGNOSIS 2019-2027 ($ MILLION)
FIGURE 6 ASIA-PACIFIC METAGENOMICS MARKET BY
BIOTECHNOLOGY 2019-2027 ($ MILLION)
FIGURE 7 ASIA-PACIFIC METAGENOMICS MARKET BY
ENVIRONMENTAL REMEDIATION 2019-2027 ($ MILLION)
FIGURE 8 ASIA-PACIFIC METAGENOMICS MARKET BY
BIOFUEL 2019-2027 ($ MILLION)
FIGURE 9 ASIA-PACIFIC METAGENOMICS MARKET BY
AGRICULTURE 2019-2027 ($ MILLION)
FIGURE 10 ASIA-PACIFIC METAGENOMICS MARKET BY
CONSUMABLES 2019-2027 ($ MILLION)
FIGURE 11 ASIA-PACIFIC METAGENOMICS MARKET BY
INSTRUMENTS 2019-2027 ($ MILLION)
FIGURE 12 ASIA-PACIFIC METAGENOMICS MARKET BY SOFTWARE
2019-2027 ($ MILLION)
FIGURE 13 JAPAN METAGENOMICS MARKET 2019-2027 ($
MILLION)
FIGURE 14 CHINA METAGENOMICS MARKET 2019-2027 ($
MILLION)
FIGURE 15 AUSTRALIA & NEW ZEALAND METAGENOMICS
MARKET 2019-2027 ($ MILLION)
FIGURE 16 INDIA METAGENOMICS MARKET 2019-2027 ($
MILLION)
FIGURE 17 SOUTH KOREA METAGENOMICS MARKET 2019-2027 ($
MILLION)
FIGURE 18 ASEAN COUNTRIES METAGENOMICS MARKET 2019-2027
($ MILLION)
FIGURE 19 REST OF ASIA-PACIFIC METAGENOMICS MARKET
2019-2027 ($ MILLION)